ThisCalculator

Everyday

Carbon Monoxide and Transplants: Can It Protect Organs?

Updated · Standard formula, shown below

Carbon monoxide (CO) may help protect transplanted organs in carefully controlled experimental settings, but it is not an established treatment that patients can use or request as routine care. Researchers are studying low, measured exposures and CO-releasing compounds because they may limit some forms of inflammation and tissue injury; uncontrolled CO exposure is poisonous and can be fatal.

Why transplant organs can be injured

Organs can sustain damage before, during, and after transplantation. A donor organ may spend hours without a normal blood supply while it is recovered, stored, and transported. When circulation is restored in the recipient, the return of oxygen and blood flow can trigger additional injury. This process is called ischemia–reperfusion injury.

The effects vary by organ and circumstance. In a kidney, early injury can contribute to delayed graft function, meaning the transplanted kidney does not work well immediately. In a liver or lung, preservation and reperfusion injury can also complicate recovery. The immune system may respond to injured tissue, but this early injury is not the same as rejection: rejection is an immune attack on the graft and requires its own diagnosis and treatment.

Transplant teams already work to reduce avoidable injury through donor assessment, preservation methods, careful surgical technique, and close monitoring after transplant. CO research is aimed at whether it might add protection to these approaches, not replace them.

How carbon monoxide might work

CO is best known as a toxic gas that interferes with the blood’s ability to carry oxygen. It binds to hemoglobin, the oxygen-carrying protein in red blood cells, and can cause tissue oxygen deprivation. At carefully controlled, low exposures, however, CO also acts as a biological signaling molecule. The body naturally produces small amounts of it when it breaks down heme, a component of hemoglobin and other proteins.

Laboratory and animal research suggests that CO signaling may influence inflammation, blood-vessel function, cell stress responses, and programmed cell death. These effects could, in theory, reduce some damage when an organ is deprived of oxygen and then reperfused. The outcome depends on factors such as dose, timing, route of delivery, organ type, and the condition of the donor and recipient. “Low dose” does not mean harmless: the margin between a potentially useful exposure and a dangerous one is a central safety challenge.

What research has—and has not—shown

Studies of CO in transplantation include laboratory experiments, animal models, and early-stage human research in limited settings. Researchers have examined approaches such as exposing an organ to controlled CO during preservation, giving CO under medical supervision, or using compounds designed to release CO. These strategies are not interchangeable, and results from one organ or experimental model cannot automatically be applied to another.

Promising findings in preclinical studies do not establish that a therapy improves long-term graft survival or outcomes that matter to patients. Small early studies may primarily assess feasibility and safety, not prove effectiveness. Larger, well-designed clinical trials are needed to determine which patients, organs, doses, and delivery methods might benefit, and whether any benefit outweighs the risks.

Accordingly, CO should not be described as a proven way to prevent rejection, guarantee a successful transplant, or improve recovery outside a research protocol. The status of individual studies can change, so people seeking current trial information should discuss it with their transplant team and consult reliable clinical-trial registries.

Delivery methods and practical limits

Researchers are investigating different ways to control where and when CO reaches tissue. Inhaled CO is difficult to use safely because it enters the bloodstream and can reduce oxygen delivery throughout the body. Organ-directed approaches may seek to limit exposure elsewhere, but they still require precise measurement and evidence that the method is safe and effective.

CO-releasing molecules are compounds intended to release CO under particular conditions. They are research tools or investigational approaches, not ordinary supplements or approved substitutes for transplant care. Their behavior, breakdown products, and effects must be evaluated for each formulation. A method that appears protective in a laboratory cannot be assumed to work in a human transplant operation.

There is no patient-facing dose or home-use method to provide here. CO is colorless and odorless, so a person cannot judge exposure by smell or appearance. Never use combustion devices, exhaust, or improvised equipment to try to deliver CO to an organ or person.

Risks and the difference from poisoning

Carbon monoxide poisoning happens when inhaled CO prevents enough oxygen from reaching the body’s tissues. Symptoms can include headache, dizziness, weakness, nausea, chest pain, and confusion; severe exposure can cause loss of consciousness, heart or brain injury, and death. Symptoms may be mistaken for a flu-like illness, and a standard fingertip pulse oximeter can give misleading reassurance during CO poisoning.

CO research uses controlled conditions and monitoring precisely because exposure can be dangerous. People with heart or lung disease, anemia, or other health vulnerabilities may face particular risks from reduced oxygen delivery, but only qualified clinicians can assess an individual situation. Clinical research has eligibility criteria, monitoring, and stopping rules; those safeguards do not make unsupervised exposure safe.

If CO poisoning is possible, leave the area for fresh air without putting yourself at risk, call emergency services, and follow their instructions. Do not wait for symptoms to worsen or try to treat suspected poisoning with a home remedy.

What transplant recipients should do

Patients should not change anti-rejection medicines, preservation plans, or other transplant care because of claims about CO. If a study or news report raises questions, ask the transplant team whether the evidence applies to the specific organ and whether a relevant clinical trial is available. A research listing alone does not mean a treatment is proven or appropriate for a particular patient.

  • Ask whether a claim comes from a cell study, an animal experiment, an early human study, or a large clinical trial.
  • Check what outcome was measured: short-term laboratory markers are not the same as graft function, complications, or survival.
  • Discuss potential risks, alternatives, and the study’s monitoring plan with the transplant team before considering research participation.
  • Use working CO alarms and maintain fuel-burning appliances safely to prevent accidental poisoning at home.

Frequently Asked Questions

Can carbon monoxide prevent transplant rejection?
No. CO research focuses mainly on possible effects on inflammation and ischemia–reperfusion injury. It has not been established as a way to prevent or treat transplant rejection, which requires assessment and management by the transplant team.

Is carbon monoxide used routinely to preserve donor organs?
It is not established as routine transplant care. CO-related preservation strategies remain investigational, and any use in a study must follow its protocol and safety oversight.

Can a transplant recipient use a CO-releasing supplement?
No such product should be treated as a transplant therapy. Investigational CO-releasing compounds are not interchangeable with supplements, and self-treatment could be dangerous or interfere with care. Ask the transplant team before taking any new product.

Is controlled carbon monoxide exposure safe?
It can still be hazardous. CO reduces oxygen delivery, and safety depends on tightly controlled exposure and medical monitoring. Do not try to create or inhale CO outside an authorized clinical setting.

What should I do if I suspect carbon monoxide poisoning?
Get to fresh air if you can do so safely, call emergency services, and follow their instructions. Do not re-enter the area or rely on a pulse oximeter to rule out poisoning.

Related

Method: the standard formula for this calculation, rounded as each result states. See how the calculators work or report an error.